By binding to angiotensin II receptor type 1 receptors, angiotensin II activates downstream MAPK and JNK signaling pathways, leading to the inhibition of the insulin signaling pathway and subsequently causing insulin resistance (Gutierrez-Rodelo et al., 2022). Here, AGT is linked to Insulin resistance.